课题基金 / 基金详情

Mechanistic analysis and therapeutic targeting of miR-122 and HCV

Mechanistic analysis and therapeutic targeting of miR-122 and HCV
miR-122 和 HCV 的机制分析和治疗靶向
批准号:
291905
负责人:
Wilson Joyce A
金额:
$36.5万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2013
资助国家:
加拿大
项目状态:
已结题
起止时间:
2013-09-01 至 2018-09-01

项目摘要

项目成果

Wilson Joyce A的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Hepatitis C virus (HCV) persists as a chronic infection in over 150 million people worldwide, and is a growing problem in Canada. New antivirals being developed will revolutionize HCV treatment in the developed world, but worldwide eradication of HCV will
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Reverse genetic analysis of mechanisms underlying convergent evolution of SARS-CoV-2 variants of concern and accessory protein functions
  • 批准号:
    484207
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2023
  • 负责人:
    Wilson Joyce A
  • 依托单位:
Unraveling the Evolution of COVID-19: The Impact of Variant Mutations and ORF8 on Virus Replication and Pathogenesis to Enhance Pandemic Preparedness
  • 批准号:
    494298
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2023
  • 负责人:
    Wilson Joyce A
  • 依托单位:
COVID-19 Variant Supplement - SARS-CoV2 therapeutic discovery through genetic screens and repurposing drugs that target essential virus-host interactions.
  • 批准号:
    443209
  • 项目类别:
    Operating Grants
  • 资助金额:
    $3.64万
  • 财政年份:
    2021
  • 负责人:
    Wilson Joyce A
  • 依托单位:
SARS-CoV2 therapeutic discovery through genetic screens and repurposing drugs that target essential virus-host interactions.
  • 批准号:
    429488
  • 项目类别:
    Operating Grants
  • 资助金额:
    $32.73万
  • 财政年份:
    2020
  • 负责人:
    Wilson Joyce A
  • 依托单位:
海外基金